The steady-state levels of p53 mRNA and protein were barely detectable by Northern and Western blot analysis in spontaneously immortalized (10)3 and (10)7 murine embryo ®broblast (MEF) cells. But when cells were treated with cycloheximide (CHX) or emetine, expression levels were restored to those observed in primary and immortal (10)10 MEF cells. However, levels of p53 mRNA were not changed in primary or (10)10 MEF cells by CHX treatment. De novo p53 mRNA synthetic rates were similar in primary, (10)10, (10)3, and (10)7 MEF cells treated with or without CHX. Treatment with actinomycin D (ActD) showed that p53 mRNA in primary and (10)10 MEF cells had a relatively long half-life of 22 h, compared to less than 2 h for (10)3 and (10)7 MEF cells. Pulse-chase analysis of p53 mRNA turnover using CHX and ActD showed that the rapid destabilization of p53 mRNA in (10)3 and (10)7 MEF cells could be regulated at the transcriptional and translational levels. In addition, the destabilization of p53 mRNA appeared to occur in the nucleus for (10)3 and (10)7 cells, but not for primary and (10)10 MEF cells. Taken together, the present study demonstrates that inactivation of the p53 gene occurs at the posttranscriptional level by rapid destabilization of its mRNA in the nucleus of spontaneously immortalized (10)3 and (10) Keywords: p53 mRNA; immortal MEF; half-life; cycloheximide; emetine; actinomycin D
Results and Discussion
In normal cells, p53 acts as a transcriptional activator or repressor and functions by arresting cell growth or triggering cell death in response to a variety of cellular stresses (Giaccia and Kastan, 1998) . The functional inactivation of p53 by protein degradation or through mutations within the gene is commonly detected in a wide spectrum of immortal and tumor cells (Levine et al., 1994) . Degradation of p53 protein is regulated by ubiquitin-dependent proteolysis through an interaction with either MDM-2, one of the p53-regulated genes (Haupt et al., 1997; Kubbutat et al., 1997) or human papillomavirus E6 oncoprotein (Schener et al., 1990) . Simian virus 40 large T antigen also inhibits the biological function of p53 by preventing the protein from interacting with its cognate consensus binding sequence (Jiang et al., 1993) . Despite numerous studies that have focused on the molecular mechanisms underlying the functional inactivation of p53 at the translational and post-translational levels, relatively little is known about the regulation of p53 at the transcriptional and post-transcriptional levels.
Of the 11 spontaneously immortalized murine embryo ®broblast (MEF) cell lines that were originally established from BALB/c primary MEF cells using the 3T3 culture schedule (Harvey and Levine, 1991) , we used three of these cell lines [(10)10, (10)3 and (10)7] to compare the altered expression of p53. The p53 gene in (10)10 cells was shown to have a missense mutation at amino acid 275, thereby changing the proline (CCT) to an arginine (CGT). The (10)3 cells have a nonsense mutation at amino acid 173 that causes cysteine (TGC) to become a stop codon (TGA), whereas there are no obvious mutations in the p53 gene in (10)7 cells. Although p53 mRNA and protein were shown to be expressed in (10)10 MEF cells, both the (10)3 and (10)7 MEF cells did not express detectable levels of p53 mRNA and protein as determined by Northern blot and immunoprecipitation assays (Harvey and Levine, 1991) . Therefore, the inactivation of the p53 gene in two of the 11 immortal clonally derived MEF cells [(10)3 and (10)7] is quite dierent compared to that observed in a variety of immortal and tumor cells where p53 protein is commonly inactivated by a missense mutation, such as the one found in the (10)10 MEF cells. Furthermore, since we have recently established six immortal chicken embryo ®broblast cell lines, all of which have shown similar p53 mRNA down-regulation, the mechanism leading to the functional inactivation of the p53 via the down-regulation of its mRNA may not be species-speci®c (Kim et al., 2001) .
The transcriptional activity of p53 causes cell cycle arrest or apoptosis by up-regulating a variety of genes such as p21 WAF , MDM-2, and Bax, while the loss of its transcriptional activity is commonly found in various Oncogene (2001) 20, 3306 ± 3310 immortal and tumor cells (Ko and Prives, 1996) . We analysed the expression of p53-regulated downstream genes such as p21 WAF and MDM-2 to determine whether the altered p53 status due to a point mutation in (10)10 cells or a lack of mRNA expression in (10)3 and (10)7 cells caused an identical loss of function as a transcriptional activator. The steady-state mRNA levels of p21 WAF and MDM-2 were dramatically decreased in all three immortal MEF cells compared to primary passage 2 MEF cells ( Figure 1a) . Furthermore, the down-regulation of steady-state levels of p21 WAF and MDM-2 proteins evidently re¯ected their diminished mRNA levels in immortal (10)10, (10)3 and (10)7 cells ( Figure 1b) . To further address the biological eects of reduced p53 mRNA expression, we measured the transcriptional activity of p53 by consensus DNA binding kinetic analysis. We transfected a p53 consensus binding sequence promoter/ luciferase reporter plasmid construct into primary and three immortal MEF cells ( Figure 1c ). In contrast to the activity in primary MEF cells in which transcriptional activity of p53 was shown to be elevated *7.2-fold in the presence of mitomycin C, one of the DNA damaging agents, the overall transcriptional activity in (10)10, (10)3, and (10)7 MEF cells was essentially equal regardless of the presence or absence of mitomycin C ( Figure 1c ). Together, these results suggest that the complete loss of p53 functional activity occurred as a result of either a mutated p53 protein (in the case of (10)10 cells) or the down-regulation of p53 mRNA (in the case of (10)3 and (10)7 cells). The general concept of transcriptional regulation related to the steady-state levels of mRNA prompted us to determine whether loss of p53 mRNA expression in (10)3 and (10)7 cells could have resulted from either decreased de novo mRNA synthesis or increased mRNA decay rates, or both (Jackson et al., 2000) . We therefore compared the steady-state levels of p53 mRNA after treating primary and immortal MEF cells with the protein synthesis inhibitor, cycloheximide (CHX) (Yeilding et al., 1998) . As determined by Northern blot and semi-quantitative reverse transcription polymerase chain reaction (RT ± PCR) analysis (Figure 2a) , the expression levels of p53 mRNA in primary and (10)10 MEF cells were relatively unchanged in the presence or absence of CHX. Conversely, when (10)3 and (10)7 MEF cells were treated with CHX, the expression of p53 mRNA was completely restored to levels found in primary MEF and (10)10 cells. To further address if p53 mRNA restoration in (10)3 and (10)7 MEF cells is mediated speci®cally through the protein synthesis inhibitor, CHX, we treated primary and three immortal MEF cells with emetine (other inhibitor of protein synthesis). In the presence of emetine, the expression of Figure 1 Expression of p53, p53-regulated genes, and altered functional activity of p53 in primary and immortal MEF cells. Primary BALB/c MEF and spontaneously immortalized (10)10, (10)3 and (10)7 MEF cell lines were maintained in 10% FBS-DMEM medium (Life Technologies) as described previously (Harvey and Levine, 1991) . (a) Total RNA was isolated using TRIzol (Life Technologies) from all exponentially growing primary (MEF18 passage 2) and immortal MEF cells. For semiquantitative RT ± PCR, DNase I-treated RNA (3 mg) was converted to cDNA with Superscript II reverse transcriptase (Life Technologies) following the manufacturer's instructions. A portion of the reverse transcription mixture (1/20 volume) was used to amplify each of the various mouse cDNA fragments using mouse-speci®c primers. All mouse cDNA fragments were ampli®ed using TaKaRa Ex Taq (Intergen) at 958C for 30 s, 658C for 1 min and 728C for 45 s for 18 cycles. The steady-state levels of p53, p21 WAF , MDM-2 and GAPDH were detected by hybridizing RT ± PCR fragments with their corresponding cDNA probes. (b) Cell extracts (100 mg) from primary MEF18 passage 2) and immortal MEF cells was resolved on 12% SDS ± PAGE and transferred onto PVDF membrane (Millipore). Immunoblotting of the membranes was performed using a 1 : 1000 dilution of antihuman p53 antibody (Ab-3, Oncogene), a 1 : 1000 dilution of antimouse p21 WAF antibody (SX118, PharMingen), a 1 : 1000 dilution of anti-mouse MDM-2 antibody (sc-965, Santa Cruz Biotechnology, Inc.), and a 1 : 1000 dilution of anti-chicken actin antibody (Ab-1, Oncogene), followed by treatment with HRP-conjugated anti-mouse IgG antibody (Amersham Pharmacia Biotech). All mouse p53, p21 WAF , MDM-2, and actin were detected by the Enhanced Chemiluminescence System (Amersham Pharmacia Biotech) following manufacturer's instructions. (c) Doublestranded oligonucleotides corresponding to tetramers of the p53 consensus binding sequences were cloned into the pGL3 Luciferase reporter vector (Promega). Transient transfection was carried out using standard calcium phosphate precipitation. Ten mg of p53-Luciferase promoter reporter plasmids was transiently transfected together with 2 mg of pcDNA 3.1 LacZ plasmid to normalize transfection eciency. Reporter gene activity was measured 24 h after transfection. Cells grown in the presence (+; 5 mg ml) or absence (7) of mitomycin C (Sigma) for 16 h were lysed with TRIzol, and total RNA was isolated and treated with RNase-free DNase I to eliminate possible genomic or transfected plasmid DNA contamination. Expression levels of luciferase mRNA were determined by semi-quantitative RT ± PCR, using the identical methods as described for RT ± PCR (a), and quanti®ed using the NIH image program. The relative expression levels of the luciferase reporter gene were normalized using the expression levels of GAPDH and LacZ genes Oncogene Post-transcriptional down-regulation of murine p53 mRNA H Kim et al p53 mRNA in (10)3 and (10)7 MEF cells was shown to be restored to levels similar to CHX-treated cells (Figure 2b ). We also con®rmed that the expression levels of p53 mRNA in (10)3 and (10)7 cells were stabilized within 2 h in the presence of CHX (data not shown) or emetine (Figure 2b ). These results strongly suggest that protein synthesis inhibition per se could be implicated in the expression of p53 mRNA in these MEF cells.
To determine whether the increased p53 mRNA levels in (10)3 and (10)7 cells were the result of increased de novo mRNA synthesis or increased mRNA stability or both, we examined the transcription rates of p53 mRNA using in vitro nuclear run-on assays. Interestingly, the de novo synthetic p53 mRNA rates were not changed in primary cells (passage 2) or any of the three immortal MEF cells grown in the presence or absence of CHX (Figure 3a) , suggesting that the down-regulation of p53 mRNA in (10)3 and (10)7 MEF cells does not result from decreased synthesis, and that p53 mRNA transcription is not altered by CHX.
Although p53 protein has a very short 15 ± 30 min half-life in normal cells, relatively little is known about the half-life of the p53 transcript. To address this question, we used actinomycin D (ActD) to determine that the half-life of p53 mRNA in primary MEF cells was a relatively long 22 h (Figure 3b) . As a control, the rapidly destabilizing transcript, c-Myc (Herrick and Ross, 1994) , showed an expected 45 min half-life using Figure 2 The eects of protein synthesis inhibitors on p53 mRNA expression. The steady-state levels of p53 mRNA in primary passage 2 (MEF18) and three immortal MEF cells grown in the presence or absence of CHX (Sigma, 50 mg ml) for 4 h or emetine (Calbiochem, 300 mM) for dierent times (0, 2, 4 and 6 h) were determined by Northern blot (a) and semi-quantitative RT ± PCR analysis (b and c). GAPDH was used to con®rm equal RNA levels for either Northern blot or RT ± PCR. For Northern blot analysis, membranes were blotted with 20 mg of total RNA extracted from dierent MEF cells then hybridized with PCRderived mouse p53 and GAPDH probes using standard hybridization conditions. Consistent results were con®rmed from more than ®ve independent experiments Figure 3 In vitro transcription rate and half-life of p53 mRNA. (a) De novo synthesized p53 mRNA levels were determined by nuclear run-on assays (Madisen et al., 1998) . Nuclei from 1610 8 primary (MEF18 passage 2) and immortal MEF cells grown in the absence or presence of CHX (50 mg ml) for 4 h were isolated. Labeled RNA was hybridized with membranes slotblotted with p53, pBluescript SK vector (negative control), and GAPDH (positive control) DNA. Speci®c signals were analysed using the NIH image program. REL ratios indicate relative expression levels normalized with GAPDH. (b) To determine the half-life of p53 mRNA, primary MEF cells (passage 2) were treated with actinomycin D (Act D; 5 mg ml) for increasing times (0.5, 1, 3, 6, 10, 16 and 24 h). The expression levels of p53 were determined by RT ± PCR. Levels of c-Myc mRNA were also examined to con®rm transcriptional inhibition by ActD. The p53 and c-Myc mRNA levels from three independent experiments were quanti®ed using the NIH image program. (c) To determine the half-life of p53 mRNA in immortal (10)3 and (10)7 MEF cells, CHX (50 mg ml) pretreatment was performed in order to increase p53 transcript to levels found in primary and (10)10 MEF cells. After 4 h, medium was removed and replaced with either medium alone or medium containing ActD (5 mg ml). Total RNA was isolated from (10)3 and (10)7 MEF cells at time points indicated. Total RNA was also prepared from both primary and (10)10 MEF cells grown under identical culture conditions. The expression levels of p53 were determined by semi-quantitative RT ± PCR. Identical results were obtained from at least three independent experiments the same experimental conditions (Figure 3b ). The relatively long-lived murine p53 mRNA was not species-speci®c, since primary chicken embryo ®bro-blasts also showed a similar rate of p53 mRNA metabolism (data not shown). The half-life of p53 mRNA in (10)3 and (10)7 MEF cells was compared to primary and (10)10 MEF cells, by allowing cells to grow in the presence of CHX for 4 h in order to restore p53 mRNA to levels found in primary MEF and (10)10 cells. After the CHX containing culture medium was washed out, primary and immortal (10)10, (10)3 and (10)7 MEF cells were allowed to grow in fresh medium with or without ActD. The expression levels of p53 mRNA in all primary and immortal MEF cells were determined at increasing lengths of time (Figure 3c ). Levels of p53 mRNA were markedly increased in (10)3 and (10)7 MEF cells following CHX treatment (lane 2 in Figure 3c ). In contrast, p53 mRNA levels were relatively unchanged in primary and (10)10 MEF cells with or without ActD (lanes 3 through 10 in Figure 3c ). The level of p53 mRNA in (10)3 and (10)7 MEF cells rapidly decreased in medium without ActD (lanes 5 and 6 in Figure 3c ) with a halflife of less than 2 h. On the other hand, in (10)3 and (10)7 MEF cells, ActD treatment without pretreatment of CHX did not increase the amount of p53 mRNA to levels found in primary and (10)10 MEF cells (data not shown). ActD treatment with pretreatment of CHX markedly increased the stability of p53 mRNA (lanes 7 through 10 in Figure 3c ). Together, these results suggest that the down-regulation of p53 mRNA in (10)3 and (10)7 MEF cells may be caused by certain destabilizing determinants that could be regulated at both the transcriptional and translational level.
To localize where the rapid destabilization of p53 mRNA occurred, we compared the expression levels of p53 mRNA in the nuclei and cytoplasm of primary and immortal (10)10, (10)3, (10)7 MEF cells grown in the presence or absence of CHX. Surprisingly, the steady-state levels of p53 mRNA decreased in the nuclei of (10)3 and (10)7 MEF cells, but could be restored by either CHX (Figure 4a ) or emetine ( Figure  4c ) treatment, in contrast to the results observed in primary and (10)10 MEF cells. We also con®rmed by semi-quantitative RT ± PCR that cytoplasmic p53 mRNA was barely detectable in (10)3 and (10)7 MEF cells, but was restored to normal levels by either CHX (Figure 4b ) or emetine (Figure 4d ) treatment. Together, these results suggest that most of the p53 mRNA destabilization occurred in the nucleus, albeit further degradation appeared to occur to the cytoplasm.
This nuclear destabilization of p53 mRNA diers from the polysome-associated decay observed in the cytoplasm for most of the short-lived mRNAs such as c-Myc (Herrick and Ross, 1994; Yeilding et al., 1998) , c-Fos (Shyu et al., 1989) , and the various cytokines (Jarzembowski and Malter, 1997). Figure 4 Destabilization of p53 mRNA occurs in the nuclei of (10)3 and (10)7 MEF cells. Nuclei and cytoplasm from primary (MEF18) and immortal (10)10, (10)3, and (10)7 MEF cells were separated as described for nuclear run-on assays (Madisen et al., 1998) . Total RNA was isolated from nuclear and cytoplasmic fractions, respectively, using TRIzol. The steady-state levels of p53 mRNA in nuclei (CHX, a; emetine, c) and cytoplasm (CHX, b; emetine, d) were determined by semi-quantitative RT ± PCR and Northern blot analysis (data not shown). The p53 mRNA levels obtained from three independent experiments were quantitated using the NIH image program. The p53 mRNA levels from cells grown without CHX or emetine were set to 1. The REL ratios indicate relative expression levels normalized with GAPDH Oncogene Post-transcriptional down-regulation of murine p53 mRNA H Kim et al Recently, numerous elegant studies have also demonstrated that mRNA stability is regulated by nonsense-mediated mRNA decay (NMD) that occurs either in the cytoplasm or the nucleus of mammalian cells (reviewed by Maquat and Carmichael, 2001) . NMD is a mechanism that leads to the downregulation of mRNA translation and activation of mRNA degradation as a consequence of the premature termination of translation. Therefore, it is plausible that the destabilization of p53 mRNA may be mediated by NMD in (10)3 MEF cells where the p53 gene has a nonsense mutation that results in premature translation termination.
In conclusion, the loss of p53 functional activity by either point mutations, protein degradation, or rapid destabilization of its mRNA seems to have similar consequences for cellular immortalization for the three cell lines analysed in this report. Certain immortalized murine ®broblast lines such as clone A31 Balb 3T3 ®broblasts, Swiss 3T3 ®broblasts and others do express detectable levels of functional p53, suggesting that alternative pathways must certainly exist for cellular immortalization. The mechanism(s) underlying rapid destabilization of p53 mRNA should be further characterized to help us understand events not only for cellular immortalization but also for mRNA metabolism in the nucleus.
